Equities

Alliance Pharma PLC

APH:LSE

Alliance Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)37.60
  • Today's Change0.10 / 0.27%
  • Shares traded455.67k
  • 1 Year change-23.65%
  • Beta0.8975
Data delayed at least 20 minutes, as of Jul 05 2024 16:35 BST.
More ▼

Profile data is unavailable for this security.

About the company

Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.

  • Revenue in GBP (TTM)180.68m
  • Net income in GBP-33.14m
  • Incorporated2001
  • Employees292.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Mayne Pharma Group Ltd146.72m-136.38m196.35m900.00196.35m900.00
Duopharma Biotech Bhd115.58m7.51m199.33m1.94k199.33m1.94k
Alliance Pharma plc180.68m-33.14m203.25m292.00203.25m292.00
Aurora Cannabis Inc154.67m-31.65m205.06m1.07k205.06m1.07k
SMS Pharmaceuticals Ltd66.30m4.66m205.77m1.10k205.77m1.10k
Panion & BF Biotech Inc47.52m2.37m206.53m321.00206.53m321.00
Data as of Jul 05 2024. Currency figures normalised to Alliance Pharma PLC's reporting currency: UK Pound GBX

Institutional shareholders

37.45%Per cent of shares held by top holders
HolderShares% Held
Slater Investments Ltd.as of 21 Sep 202354.12m10.02%
Rathbones Investment Management Ltd.as of 06 Oct 202325.97m4.81%
Fidelity Management & Research Co. LLCas of 17 Mar 202319.64m3.64%
Artemis Investment Management LLPas of 29 Feb 202417.35m3.21%
Investec Wealth & Investment Ltd.as of 17 Mar 202317.26m3.20%
Van Lanschot Kempen Investment Management NVas of 18 Jun 202415.02m2.78%
RBC Global Asset Management (UK) Ltd.as of 25 Aug 202314.55m2.69%
Rowan Dartington & Co. Ltd. (Broker)as of 01 Mar 202414.40m2.66%
Polar Capital LLPas of 01 Mar 202412.12m2.24%
Brooks Macdonald Asset Management Ltd.as of 01 Mar 202411.94m2.21%
More ▼
Data from 28 Dec 2023 - 01 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.